ConductScience.org, home

Paper33922018

A Central Role for Ischemia and OCTA Metrics to Follow DR Progression.

Cunha-Vaz J. J Clin Med, 2021. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. A Central Role for Ischemia and OCTA Metrics to Follow DR Progression. Papers, record 33922018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33922018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Central Role for Ischemia and OCTA Metrics to Follow DR Progression.
PubMed
Journal
J Clin Med
PubMed
Year
2021
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2024-04-02
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cunha-Vaz JJosé

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1885298Relationship of microvascular disease in diabetes to metabolic control.Diabetes1977https://conductscience.org/library/papers/885298PubMed
26022598Studies on the effects of osmotically active substances on the circulation and structure of the retina. I. Observations in vivo.Invest Ophthalmol1967https://conductscience.org/library/papers/6022598PubMed
323204247Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.Diabetes Care2013https://conductscience.org/library/papers/23204247PubMed
44138036Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973.Br J Ophthalmol1974https://conductscience.org/library/papers/4138036PubMed
532181799Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study.Invest Ophthalmol Vis Sci2020https://conductscience.org/library/papers/32181799PubMed
633025221Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.Acta Diabetol2021https://conductscience.org/library/papers/33025221PubMed
730523027Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients.Diabetes2019https://conductscience.org/library/papers/30523027PubMed
833355147Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR.Br J Ophthalmol2022https://conductscience.org/library/papers/33355147PubMed
96360771Experimental galactosemia produces diabetic-like retinopathy.Diabetes1984https://conductscience.org/library/papers/6360771PubMed
1014081839CAPILLARY SHUNTS IN THE PATHOGENESIS OF DIABETIC RETINOPATHY.Diabetes1963https://conductscience.org/library/papers/14081839PubMed
1128301651Quantification of Retinal Microvascular Density in Optical Coherence Tomographic Angiography Images in Diabetic Retinopathy.JAMA Ophthalmol2017https://conductscience.org/library/papers/28301651PubMed
1231382265Unmet Needs in Ophthalmology: A European Vision Institute-Consensus Roadmap 2019-2025.Ophthalmic Res2019https://conductscience.org/library/papers/31382265PubMed
1334070479Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study.J Clin Med2021https://conductscience.org/library/papers/34070479PubMed
1427114552Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27114552PubMed
1524680929Phenotypes and biomarkers of diabetic retinopathy.Prog Retin Eye Res2014https://conductscience.org/library/papers/24680929PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
40646245Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging.Eye (Lond)2025https://conductscience.org/library/papers/40646245PubMed
40103950Changes in retinal capillary density in female with type 2 diabetes and gestational diabetes-an analysis based on OCTA technology.Int J Ophthalmol2025https://conductscience.org/library/papers/40103950PubMed
39639890Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study.Ophthalmol Sci2025https://conductscience.org/library/papers/39639890PubMed
34661732Zone-wise examination of optical coherence tomography features and their correspondence to multifocal electroretinography in eyes with nonproliferative diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol2022https://conductscience.org/library/papers/34661732PubMed
34063514Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study.J Clin Med2021https://conductscience.org/library/papers/34063514PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33922018

GET https://conductscience.org/api/papers/v1/33922018/authors